Authors: Maki, T Nasa, Y Yamaguchi, F Yoshida, H Mori, M Takada, T Horikawa, E Okano, K Takeo, S

Citation: T. Maki et al., Long-term treatment with neutral endopeptidase inhibitor improves cardiac function and reduces natriuretic peptides in rats with chronic heart failure, CARDIO RES, 51(3), 2001, pp. 608-617

Authors: Yoshida, H Takahashi, M Tanonaka, K Maki, T Nasa, Y Takeo, S

Citation: H. Yoshida et al., Effects of ACE inhibition and angiotensin II type 1 receptor blockade on cardiac function and G proteins in rats with chronic heart failure, BR J PHARM, 134(1), 2001, pp. 150-160

Authors: Takeo, S Nasa, Y Tanonaka, K Yamaguchi, F Yabe, K Hayashi, H Dhalla, NS

Citation: S. Takeo et al., Role of cardiac renin-angiotensin system in sarcoplasmic reticulum function and gene expression in the ischemic-reperfused heart, MOL C BIOCH, 212(1-2), 2000, pp. 227-235

Authors: Takeo, S Kajiwara, H Tanonaka, K Nasa, Y Nakajima, Y Ohya, Y Kaizuka, Y

Citation: S. Takeo et al., Cardioprotective effect of a novel cyclohexane dicarboximide derivative, ST-6, against ischemia/reperfusion injury, DRUG DEV R, 51(1), 2000, pp. 20-28

Authors: Takeo, S Nasa, Y

Citation: S. Takeo et Y. Nasa, Role of energy metabolism in the preconditioned heart - a possible contribution of mitochondria, CARDIO RES, 43(1), 1999, pp. 32-43

Authors: Yamaguchi, F Kawana, K Tanonaka, K Kamano, I Igarashi, T Gen, E Fujimoto, Y Maki, T Sanbe, A Nasa, Y Takeo, S

Citation: F. Yamaguchi et al., Improvement of exercise capacity of rats with chronic heart failure by long-term treatment with trandolapril, BR J PHARM, 126(7), 1999, pp. 1585-1592